Profound Medical (PROF) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.97

Median Target+92.63%

$11.50

Potential upside vs current price

Current Stock Price

$5.97

Median Target+92.63%

$11.50

Potential upside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.97

Median Target+92.63%

$11.50

Potential upside vs current price

Current Stock Price

$5.97

Median Target+92.63%

$11.50

Potential upside vs current price

Profound Medical Corp.